Humanwell's controlling shareholder reorganization plan approved by creditors
Humanwell Healthcare Group (SSE:600079) announced that the reorganization plan for its controlling shareholder, Wuhan Dangdai Science and Technology Industries Group Co., Ltd., has been approved by creditors at the second creditors' meeting. The plan received the required approvals from various creditor groups, including secured creditors (with 81.87% of the debt value approving), unsecured creditors (70.95%), employee creditors (100%), and tax creditors (100%). The plan also received approval from the investor group. The company cautioned that the plan is still subject to court approval and that uncertainty remains regarding potential changes to the controlling shareholder and actual controller. Humanwell stressed that it maintains independent operations and that the reorganization will not impact its daily operations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Humanwell Healthcare Group publishes news
Free account required • Unsubscribe anytime